Hydreight Technologies Inc. (HYDTF)
| Previous Close | 0.3500 |
| Open | 0.3500 |
| Bid | 0.3142 x 0 |
| Ask | 0.4400 x 0 |
| Day's Range | 0.3500 - 0.3500 |
| 52 Week Range | 0.1504 - 0.4120 |
| Volume | |
| Avg. Volume | 15,834 |
| Market Cap | 14.11M |
| Beta (5Y Monthly) | -0.12 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0300 |
| Earnings Date | Nov 18, 2024 - Nov 22, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireHydreight Provides Corporate Update Reflecting Significant Growth
Hydreight reported record Topline¹ Revenue of $10.46M in the first 6 months of 2024.Q2, 2024 GAAP revenue was $4.10 million an increase of 52% compared to Q2, 2023.Q2, 2024 Adjusted EBITDA¹ was $218K compared to ($456K) in the comparative quarter.In partnership with two other companies, Hydreight launched Telemedicine and e-Commerce Solution that helps companies launch a Direct to Consumers Healthcare brand In All 50 States.Within the first 90 days, VSDHOne sold over 200 licenses across 50 State
- GlobeNewswire
Hydreight Announces Normal Course Issuer Bid
LAS VEGAS and VANCOUVER, British Columbia, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) (FSE:SO6) (the “Company”), a fast-growing mobile clinical network and medical platform which enables flexible at-home medical services across 50 states in the United States, announces today its intention to make a normal course issuer bid (the "Bid") to purchase for cancellation, from time to time, as it considers advisable, up to 1,378,633 of its issued and outst
Simply Wall St.Hydreight Technologies Second Quarter 2024 Earnings: CA$0.001 loss per share (vs CA$0.012 loss in 2Q 2023)
Hydreight Technologies ( CVE:NURS ) Second Quarter 2024 Results Key Financial Results Revenue: CA$4.10m (up 52% from 2Q...
